Advanced cardiac delivery tools exist for myocardial therapies, but progress in molecular virology and ischaemic heart disease pathophysiology lags behind. Further research is needed to fully leverage these stem cell and vector delivery systems.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: